US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DBV Technologies S.A. | $19.49 | 0.1% | $1669.52T | -0.7 | 11.8% | — | Healthcare | 110.7% | -100% | ||
| 2 | argenx SE | $794.70 | -2% | $49.18B | 62.2 | 167.1% | — | Healthcare | 21% | 335.2% | ||
| 3 | Abivax S.A. | $123.78 | 5.7% | $9.79B | -37.8 | 12% | — | Healthcare | 1638.5% | 125.1% | ||
| 4 | Kymera Therapeutics, Inc. | $82.71 | -1.1% | $6.75B | -22.4 | -15.5% | — | Healthcare | 146.3% | -12.6% | ||
| 5 | Protagonist Therapeutics, Inc. | $99.28 | -0.4% | $6.21B | -48.4 | -148.8% | — | Healthcare | 124.2% | -100% | ||
| 6 | TG Therapeutics, Inc. | $36.10 | 1.1% | $5.7B | 240.7 | -38.1% | — | Healthcare | -4.2% | 31% | ||
| 7 | Apogee Therapeutics, Inc. | $83.29 | -0.3% | $5.7B | -19.7 | -27.1% | — | Healthcare | 111.4% | — | ||
| 8 | Immunovant, Inc. | $27.84 | -0% | $5.66B | -10.2 | -2.7% | — | Healthcare | 82.9% | — | ||
| 9 | Apellis Pharmaceuticals, Inc. | $40.97 | 0% | $5.19B | 227.6 | 99.4% | — | Healthcare | 105.1% | -11.8% | ||
| 10 | Spyre Therapeutics, Inc. | $70.94 | 2.6% | $4.27B | -22.3 | 83.7% | — | Healthcare | 403.5% | — | ||
| 11 | Kiniksa Pharmaceuticals, Ltd. | $56.74 | -1.5% | $4.21B | 75.7 | 471.4% | — | Healthcare | 104.2% | 56.7% | ||
| 12 | Dianthus Therapeutics, Inc. | $90.24 | 1% | $3.9B | — | 96.9% | — | Healthcare | 318.7% | -67.3% | ||
| 13 | Oruka Therapeutics, Inc. | $68.99 | 3.8% | $3.34B | -13.8 | 46.4% | — | Healthcare | 591.3% | — | ||
| 14 | Alumis Inc. Common Stock | $26.13 | 3.5% | $3.07B | -9.1 | 14.3% | — | Healthcare | 493.9% | — | ||
| 15 | AnaptysBio, Inc. | $69.32 | -0.7% | $2.99B | -150.7 | 90.1% | — | Healthcare | 401.6% | 157% | ||
| 16 | Vera Therapeutics, Inc. | $34.52 | -2.8% | $2.46B | -7.4 | -61.8% | — | Healthcare | 35.2% | — | ||
| 17 | Aurinia Pharmaceuticals Inc. | $16.04 | 1.7% | $2.12B | 7.7 | 4615.3% | — | Healthcare | 94.2% | 20.4% | ||
| 18 | Galapagos N.V. | $28.39 | -0.1% | $1.87B | 5.0 | 345.3% | — | Healthcare | 4.6% | 303.5% | ||
| 19 | Nektar Therapeutics | $84.16 | -3.1% | $1.65B | -8.6 | 36.8% | — | Healthcare | 716.3% | -32.8% | ||
| 20 | KalVista Pharmaceuticals, Inc. | $26.71 | 0.2% | $1.37B | -7.2 | -10.2% | — | Healthcare | 103.9% | — | ||
| 21 | MoonLake Immunotherapeutics | $17.01 | -3.1% | $1.21B | -4.8 | -86.8% | — | Healthcare | -59.4% | — | ||
| 22 | Zenas BioPharma, Inc. | $20.76 | -3.7% | $1.13B | -2.5 | -116.4% | — | Healthcare | 84.7% | 100% | ||
| 23 | Omeros Corporation | $14.77 | -0.9% | $1.03B | -5.5 | 12.6% | — | Healthcare | 116.9% | — | ||
| 24 | Ventyx Biosciences, Inc. | $14.00 | 0% | $999M | -7.1 | 36.4% | — | Healthcare | 914.5% | — | ||
| 25 | Jade Biosciences, Inc. | $25.26 | 3% | $824M | -6.2 | 90.1% | — | Healthcare | 119.7% | — | ||
| 26 | Gyre Therapeutics, Inc. | $7.78 | -1.8% | $755M | 345.8 | 662.5% | — | Healthcare | -11.7% | 10.2% | ||
| 27 | Annexon, Inc. | $5.72 | 0.5% | $626M | -5.7 | -34.3% | — | Healthcare | 216% | — | ||
| 28 | FibroGen, Inc. | $7.50 | 0.3% | $585M | -15.6 | 678.3% | 0.3% | Healthcare | -5.7% | -218.3% | ||
| 29 | Climb Bio, Inc. | $11.45 | 18.2% | $547M | -13.0 | 58.2% | — | Healthcare | 816% | — | ||
| 30 | Rigel Pharmaceuticals, Inc. | $28.09 | -4.9% | $519M | 1.4 | 804.3% | — | Healthcare | 47% | 47.6% | ||
| 31 | Zura Bio Limited | $5.18 | -2.6% | $337M | -4.9 | -94.7% | — | Healthcare | 259.7% | — | ||
| 32 | Avalo Therapeutics, Inc. | $16.26 | 18% | $301M | -2.8 | 95% | — | Healthcare | 223.9% | -147.4% | ||
| 33 | RAPT Therapeutics, Inc. | $58.01 | 0% | $296M | -2.3 | 50.2% | — | Healthcare | 693.5% | — | ||
| 34 | Eledon Pharmaceuticals, Inc. | $3.78 | 0% | $226M | -0.1 | 78.8% | — | Healthcare | 21.9% | — | ||
| 35 | Cartesian Therapeutics, Inc. | $7.39 | 6.6% | $196M | -1.5 | -325.7% | — | Healthcare | -40.6% | -94.8% | ||
| 36 | Tiziana Life Sciences Ltd | $1.43 | 2.9% | $182M | -6.5 | -70.8% | — | Healthcare | 17.2% | — | ||
| 37 | InflaRx N.V. | $1.97 | -7.5% | $142M | -2.6 | 16.1% | — | Healthcare | 19.4% | -83% | ||
| 38 | Tharimmune, Inc. | $3.54 | 4.9% | $140M | -0.4 | 64.2% | — | Healthcare | 126.9% | — | ||
| 39 | Connect Biopharma Holdings Limited | $2.47 | -0.4% | $137M | -8.8 | 93.6% | — | Healthcare | 212.7% | — | ||
| 40 | Corbus Pharmaceuticals Holdings, Inc. | $10.67 | 1.4% | $134M | -1.8 | 24.6% | — | Healthcare | 43.8% | — | ||
Showing 40 of 71 stocks